Literature DB >> 25252796

Laser treatment of giant xanthelasma palpebrarum.

Bartolo Corradino1, Sara Di Lorenzo1, Antonio Triolo2, Francesco Moschella1.   

Abstract

Xanthelasma palpebrarum is the most common cutaneous xanthoma. It typically presents in middle-aged and older adults, most often around the eyelids. The diagnosis is made clinically. Giant xanthelasmas palpebrarum are xanthelasmas that extensively affect the superior and inferior bilateral eyelids. Many techniques have been put forward for treating these lesions (surgical, laser, and chemical techniques), but we describe our experience in the treatment of giant xanthelasmas by ultrapulsed CO2 laser. Between 2009 and 2012, in the Division of Plastic and Reconstructive Surgery at the University of Palermo, 12 patients with giant xanthelasmas were treated using a CO2 laser. The laser parameters are as follows: frequency 20 Hz, energy 75 mJ, and power 1.5 W. Each laser session lasts 15 min; the treatment consists of three or four sessions that are carried out at intervals of 15 days. Patients were followed up after 2, 6, and 12 months. This technique is rapid and it is accepted very well by patients. The only disadvantage is a long healing time (10-15 days). The ultrapulsed CO2 laser, in experienced hands, is an excellent device that enables the complete removal of giant xanthelasmas with a minimally invasive but very effective technique.

Entities:  

Keywords:  Benign lesion of eyelid; Big xanthelasma; Conservative treatment; Eyelid surgery; Ultrapulsed CO2 laser

Mesh:

Year:  2014        PMID: 25252796     DOI: 10.1007/s10103-014-1664-7

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  10 in total

1.  Xanthelasma palpebrarum: treatment with the ultrapulsed CO2 laser.

Authors:  C Raulin; M P Schoenermark; S Werner; B Greve
Journal:  Lasers Surg Med       Date:  1999       Impact factor: 4.025

Review 2.  Xanthelasma palpebrarum: a review and current management principles.

Authors:  Rod J Rohrich; Jeffrey E Janis; Patrick H Pownell
Journal:  Plast Reconstr Surg       Date:  2002-10       Impact factor: 4.730

3.  Ultrapulse CO2 laser ablation of xanthelasma.

Authors:  T S Alster; T B West
Journal:  J Am Acad Dermatol       Date:  1996-05       Impact factor: 11.527

4.  Little tips with big rewards.

Authors:  G T Jansen
Journal:  J Dermatol Surg       Date:  1976-06

5.  Treatment of xanthelasma with Solcoderm.

Authors:  M Ronnen; S Suster; M Huszar; E Gilad
Journal:  J Am Acad Dermatol       Date:  1989-10       Impact factor: 11.527

6.  [Blepharoplasty with special reference to correction of xanthelasma].

Authors:  M Deutinger; H Koncilia; G Freilinger
Journal:  Handchir Mikrochir Plast Chir       Date:  1993-05       Impact factor: 1.018

7.  Letter: Significance of xanthelasma palpebrarum in the normal population.

Authors:  A Jónsson; N Sigfŭsson
Journal:  Lancet       Date:  1976-02-14       Impact factor: 79.321

8.  Ocular signs and symptoms of altered blood lipids.

Authors:  L J Alexander
Journal:  J Am Optom Assoc       Date:  1983-02

Review 9.  The pathogenesis and clinical significance of xanthelasma palpebrarum.

Authors:  R Bergman
Journal:  J Am Acad Dermatol       Date:  1994-02       Impact factor: 11.527

10.  Treatment of xanthelasma palpebrarum with bichloracetic acid.

Authors:  L J Haygood; J D Bennett; R T Brodell
Journal:  Dermatol Surg       Date:  1998-09       Impact factor: 3.398

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.